Cancer screening

Current Problems in Surgery

Volumn 42, Issue 9, 2005, Pages 620-682

  Jatoi, Ismail ^a   Anderson, William F ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN;

BARIUM ENEMA; BREAST CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DISEASE COURSE; EARLY DIAGNOSIS; FECES ANALYSIS; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LUNG CANCER; MAMMOGRAPHY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; OVARY CANCER; PAPANICOLAOU TEST; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PATIENT SELECTION; PREDICTION; PREVALENCE; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; RADIATION EXPOSURE; RELIABILITY; REVIEW; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM CYTODIAGNOSIS; SYSTEMATIC REVIEW; THEORETICAL STUDY; THORAX RADIOGRAPHY; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

EID: 24644482699     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2005.06.003     Document Type: Note

References (231)

1. M.R. Melamed B.J. Flehinger M.B. Zaman R.T. Heelan W.A. Perchick N. Martini Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York Chest 86 1984 44-53
2. M.S. Tockman Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study Chest 89 Suppl 4 1986 324s-325s
3. R.S. Fontana D.R. Sanderson L.B. Woolner W.F. Taylor W.E. Miller J.R. Muhm Lung cancer screening: The Mayo program J Occup Med 28 1986 746-750
4. A. Kubik D.M. Parkin M. Khlat J. Erban J. Polak M. Adamec Lack of benefit from semi-annual screening for cancer of the lung: Follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia Int J Cancer 45 1990 26-33
5. I. Jatoi Breast cancer: A systemic or local disease? Am J Clin Oncol 20 1997 536-539
6. P. Cole A.S. Morrison Basic issues in population screening for cancer J Natl Cancer Inst 64 1980 1263-1272
7. C. Nielsen R.S. Lang Principles of screening Med Clin North Am 83 1999 1323-1337 v
8. T.J. Anderson J. Lamb F. Alexander W. Lutz U. Chetty A.P. Forrest Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project Lancet 1 1986 519-523
9. F.D. Gilliland N. Joste P.M. Stauber W.C. Hunt R. Rosenberg G. Redlich Biologic characteristics of interval and screen-detected breast cancers J Natl Cancer Inst 92 2000 743-749
10. J.L. Xu P.C. Prorok Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases Stat Med 14 1995 2715-2725
11. W.C. Black H.G. Welch Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy N Engl J Med 328 1993 1237-1243
12. P.J. Klemi H. Joensuu S. Toikkanen J. Tuominen O. Rasanen J. Tyrkko Aggressiveness of breast cancers found with and without screening BMJ 304 1992 467-469
13. P.H. Peeters A.L. Verbeek H. Straatman R. Holland J.H. Hendriks M. Mravunac Evaluation of overdiagnosis of breast cancer in screening with mammography: Results of the Nijmegen programme Int J Epidemiol 18 1989 295-299
14. J.G. Schmidt The epidemiology of mass breast cancer screening - a plea for a valid measure of benefit J Clin Epidemiol 43 1990 215-225
15. S.M. Moss M.E. Summerley B.T. Thomas R. Ellman J.O. Chamberlain A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer J Epidemiol Community Health 46 1992 362-364
16. T.S. Kline The Papanicolaou smear: A brief historical perspective and where we are today Arch Pathol Lab Med 121 1997 205-209
17. E. Laara N.E. Day M. Hakama Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes Lancet 1 1987 1247-1249
18. P. Sasieni J. Cuzick E. Farmery Accelerated decline in cervical cancer mortality in England and Wales Lancet 346 1995 1566-1567
19. O.W. Brawley Prostate cancer screening: Clinical applications and challenges Urol Oncol 22 2004 353-357
20. R. Harris K.N. Lohr Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 917-929
21. R.A. Smith V. Cokkinides H.J. Eyre American Cancer Society guidelines for the early detection of cancer, 2003 CA Cancer J Clin 53 2003 27-43
22. P. Boyle Screening for prostate cancer: Have you had your cholesterol measured? BJU Int 92 2003 191-199
23. R. Zoorob R. Anderson C. Cefalu M. Sidani Cancer screening guidelines Am Fam Physician 63 2001 1101-1112
24. I.E. Smith Screening for lung cancer: Time to think positive Lancet 354 1999 86-87
25. S. Diedrich D. Wormanns Impact of low-dose CT on lung cancer screening Lung Cancer 45 Suppl 2 2004 S13-S19
26. B.S. Monsees J.M. Destouet A screening mammography program: Staying alive and making it work Radiol Clin North Am 30 1992 211-219
27. A. Salomon Beitrage zur pathologie und klinik der mammacrcinome Arch f Klin Chir 101 1913 573-668
28. S.L. Warren A roentgenologic study of the breast Am J Roentgenol 24 1930 113-124
29. J. Gershon-Cohen H. Ingleby L. Moore Can mass x-ray surveys be used in detection of early cancer of the breast? JAMA 161 1956 1069-1071
30. J. Gershon-Cohen M.B. Hermel S.M. Berger Detection of breast cancer by periodic x-ray examinations: A five-year survey JAMA 176 1961 1114-1116
31. R.L. Egan Mammography Am J Surg 106 1963 421-429
32. L.L. Humphrey M. Helfand B.K. Chan S.H. Woolf Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 5 Pt 1 2002 347-360
33. S. Shapiro Periodic screening for breast cancer: The HIP Randomized Controlled Trial. Health Insurance Plan J Natl Cancer Inst Monogr 22 1997 27-30
34. L. Nystrom I. Andersson N. Bjurstam J. Frisell B. Nordenskjold L.E. Rutqvist Long-term effects of mammography screening: Updated overview of the Swedish randomised trials Lancet 359 2002 909-919
35. N. Bjurstam L. Bjorneld S.W. Duffy T.C. Smith E. Cahlin O. Eriksson The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization Cancer 80 1997 2091-2099
36. I. Andersson K. Aspegren L. Janzon T. Landberg K. Lindholm F. Linell Mammographic screening and mortality from breast cancer the Malmo mammographic screening trial BMJ 297 1988 943-948
37. L. Tabar B. Vitak H.H. Chen S.W. Duffy M.F. Yen C.F. Chiang The Swedish Two-County Trial twenty years later updated mortality results and new insights from long-term follow-up Radiol Clin North Am 38 2000 625-651
38. F.E. Alexander T.J. Anderson H.K. Brown A.P. Forrest W. Hepburn A.E. Kirkpatrick 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening Lancet 353 1999 1903-1908
39. A.B. Miller T. To C.J. Baines C. Wall The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years Ann Intern Med 137 5 Pt 1 2002 305-312
40. A.B. Miller T. To C.J. Baines C. Wall Canadian National Breast Screening Study-2 13-year results of a randomized trial in women aged 50-59 years J Natl Cancer Inst 92 2000 1490-1499
41. Canadian study of breast screening under 50 Lancet 339 1992 1473-1474
42. D.B. Kopans Screening for breast cancer and mortality reduction among women 40-49 years of age Cancer 74 1 Suppl 1994 311-322
43. R.E. Tarone The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study Cancer 75 1995 997-1003
44. J.C. Bailar 3rd B. MacMahon Randomization in the Canadian National Breast Screening Study a review for evidence of subversion CMAJ 156 1997 193-199
45. I. Jatoi M. Baum American and European recommendations for screening mammography in younger women a cultural divide? BMJ 307 1993 1481-1483
46. T.P. Houston A.B. Elster R.M. Davis S.D. Deitchman The U.S Preventive Services Task Force Guide to Clinical Preventive Services, Second Edition. AMA Council on Scientific Affairs. Am J Prev Med 14 1998 374-376
47. K. Kerlikowske D. Grady S.M. Rubin C. Sandrock V.L. Ernster Efficacy of screening mammography a meta-analysis JAMA 273 1995 149-154
48. R.E. Hendrick R.A. Smith J.H.3rd Rutledge C.R. Smart Benefit of screening mammography in women aged 40-49 a new meta-analysis of randomized controlled trials J Natl Cancer Inst Monogr 22 1997 87-92
49. H.J. DeKonig R. Boer P.G. Warmerdam P.M. Beemsterboer P.J. van der Maas Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials J Natl Cancer Inst 87 1995 1217-1223
50. K. Kerlikowske Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years comparison of relative and absolute benefit J Natl Cancer Inst Monogr 22 1997 79-86
51. D.B. Kopans The case in favor of mammographic screening for women in their forties I. Jatoi Breast Cancer Screening 1997 Landes Bioscience Austin 9-34
52. J. Clemmesen Carcinoma of the breast Br J Radiol 21 1948 583-590
53. I.C. Henderson Biologic variations of tumors Cancer 69 7 Suppl 1992 1888-1895
54. W.C. Willett Nutritional Epidemiology 1990 Oxford University Press New York
55. D.S. Buist P.L. Porter C. Lehman S.H. Taplin E. White Factors contributing to mammography failure in women aged 40-49 years J Natl Cancer Inst 96 2004 1432-1440
56. Breast cancer screening in women under 50 Lancet 337 1991 1575-1576
57. I. Jatoi Breast cancer screening Am J Surg 177 1999 518-524
58. P.C. Gotzsche O. Olsen Is screening for breast cancer with mammography justifiable? Lancet 355 2000 129-134
59. O. Olsen P.C. Gotzsche Cochrane review on screening for breast cancer with mammography Lancet 358 2001 1340-1342
60. S.W. Duffy L. Tabar Screening mammography re-evaluated Lancet 355 2000 747-748
61. P.B. Dean Final comment The articles by Gotzsche and Olsen are not official Cochrane reviews and lack scientific merit. Lakartidningen 97 2000 3106
62. M. Baum Commentary false premises, false promises and false positives-the case against mammographic screening for breast cancer Int J Epidemiol 33 2004 66-67
63. I. Mittra Breast cancer screening by physical examination I. Jatoi Breast Cancer Screening 1997 Landes Bioscience Austin 97-110
64. M.B. Barton R. Harris S.W. Fletcher The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA 282 1999 1270-1280
65. D.M. Parkin D. Esteban Breast cancer screening by physical examination a randomized trial in the Philippines P. P. Department of Defense Era of Hope Breast Cancer Meeting, 2002. Orlando, FL 2002
66. I. Mittra M. Baum H. Thornton J. Houghton Is clinical breast examination an acceptable alternative to mammographic screening? BMJ 321 2000 1071-1073
67. F.D. Adair Clinical manifestations of early cancer of the breast, with a discussion on the subject of biopsy N Engl J Med 208 1933 1250-1255
68. V.F. Semiglazov V.M. Moiseyenko A.G. Manikhas Role of breast self-examination in early detection of breast cancer Russia/WHO propsective randomized trial in St. Petersburg. Cancer Strategy 1 1999 144-151
69. D.B. Thomas D.L. Gao R.M. Ray W.W. Wang C.J. Allison F.L. Chen Randomized trial of breast self-examination in Shanghai final results J Natl Cancer Inst 94 2002 1445-1457
70. M. Kriege C.T. Brekelmans C. Boetes P.E. Besnard H.M. Zonderland I.M. Obdeijn Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427-437
71. L. Liberman Breast cancer screening with MRI-what are the data for patients at high risk? N Engl J Med 351 2004 497-500
72. J.G. Elmore M.B. Barton V.M. Moceri S. Polk P.J. Arena S.W. Fletcher Ten-year risk of false positive screening mammograms and clinical breast examinations N Engl J Med 338 1998 1089-1096
73. S.W. Fletcher J.G. Elmore Clinical practice mammographic screening for breast cancer N Engl J Med 348 2003 1672-1680
74. S.W. Fletcher J.G. Elmore False-positive mammograms-can the USA learn from Europe? Lancet 365 2005 7-8
75. M.B. Barton S. Moore S. Polk E. Shtatland J.G. Elmore S.W. Fletcher Increased patient concern after false-positive mammograms clinician documentation and subsequent ambulatory visits J Gen Intern Med 16 2001 150-156
76. M.B. Barton D.S. Morley S. Moore J.D. Allen K.P. Kleinman K.M. Emmons Decreasing women's anxieties after abnormal mammograms a controlled trial J Natl Cancer Inst 96 2004 529-538
77. V.L. Ernster J. Barclay Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography a dilemma J Natl Cancer Inst Monogr 22 1997 151-156
78. G.D. Leonard S.M. Swain Ductal carcinoma in situ, complexities and challenges J Natl Cancer Inst 96 2004 906-920
79. M. Nielsen J.L. Thomsen S. Primdahl U. Dyreborg J.A. Andersen Breast cancer and atypia among young and middle-aged women a study of 110 medicolegal autopsies Br J Cancer 56 1987 814-819
80. C.E. Alpers S.R. Wellings The prevalence of carcinoma in situ in normal and cancer-associated breasts Hum Pathol 16 1985 796-807
81. P.P. Rosen D.W. Braun Jr D.E. Kinne The clinical significance of pre-invasive breast carcinoma Cancer 46 4 Suppl 1980 919-925
82. D.L. Page W.D. Dupont L.W. Rogers M. Landenberger Intraductal carcinoma of the breast follow-up after biopsy only Cancer 49 1982 751-758
83. I. Jatoi M. Baum Mammographically detected ductal carcinoma in situ are we overdiagnosing breast cancer? Surgery 118 1995 118-120
84. J.C. Bailar 3rd. Mammography a contrary view Ann Intern Med 84 1976 77-84
85. M. Swift D. Morrell R.B. Massey C.L. Chase Incidence of cancer in 161 families affected by ataxia-telangiectasia N Engl J Med 325 1991 1831-1836
86. J.S. Vaidya M. Baum Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations JAMA 278 1997 290
87. S.P. Poplack P.A. Carney J.E. Weiss L. Titus-Ernstoff M.E. Goodrich A.N. Tosteson Screening mammography costs and use of screening-related services Radiology 234 2005 79-85
88. H. Kattlove A. Liberati E. Keeler R.H. Brook Benefits and costs of screening and treatment for early breast cancer development of a basic benefit package JAMA 273 1995 142-148
89. P. Salzmann K. Kerlikowske K. Phillips Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Ann Intern Med 127 1997 955-965
90. A. Hackshaw EUSOMA review of mammography screening Ann Oncol 14 2003 1193-1195
91. I. Jatoi A.B. Miller Why is breast-cancer mortality declining? Lancet Oncol 4 2003 251-254
92. H.L. Howe P.A. Wingo M.J. Thun L.A. Ries H.M. Rosenberg E.G. Feigal Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends J Natl Cancer Inst 93 2001 824-842
93. A. Jemal R.C. Tiwari T. Murray A. Ghafoor A. Samuels E. Ward Cancer statistics, 2004 CA Cancer J Clin 54 2004 8-29
94. L.A.G. Ries M.P. Eisner C.L. Kosary B.F. Hankey B.A. Miller L. Clegg SEER Cancer Statistics Review, 1975-2001 2004 http://seer.cancer.gov/csr/1975-2001. December 2004.
95. P. Pisani D.M. Parkin F. Bray J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 1999 18-29
96. SEER Surveillance, Epidemiology, and End Results (SEER) Program. Public-Use Database (1973-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2003 submission 2004 www.seer.cancer.gov. December 2004.
97. R.A. Smith C.J. Mettlin K.J. Davis H. Eyre American Cancer Society guidelines for the early detection of cancer update of early detection guidelines for prostate, colorectal, and endometrial cancers CA Cancer J Clin 51 2001 38-75
98. Cancer Progress Report-2003 Update 2003 http://progressreport.cancer.gov/. December 2004.
99. J. Swan N. Breen R.J. Coates B.K. Rimer N.C. Lee Progress in cancer screening practices in the United States results from the 2000 National Health Interview Survey Cancer 97 2003 1528-1540
100. J.S. Mandel T.R. Church J.H. Bond F. Ederer M.S. Geisser S.J. Mongin The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 2000 1603-1607
101. S.J. Winawer A quarter century of colorectal cancer screening progress and prospects J Clin Oncol 19 Suppl 1 2001 6S-12S
102. P. Armitage R. Doll The age distribution of cancer and a multi-stage theory of carcinogenesis Br J Cancer 8 1954 1-12
103. P. Armitage R. Doll A two-stage theory of carcinogenesis in relation to the age distribution of human cancer Br J Cancer 11 1957 161-169
104. J.S. Bertram The molecular biology of cancer Mol Aspects Med 21 2000 167-223
105. D.W. Day The adenoma-carcinoma sequence Scand J Gastroenterol Suppl 104 1984 99-107
106. J.P. Lockhart-Mummery C. Dukes The precancerous changes in the rectum and colon Surg Gynecol Obstet 5 1928 591-596
107. B.C. Morson Genesis of colorectal cancer Clin Gastroenterol 5 1976 505-525
108. B.C. Morson Evolution of cancer of the colon and rectum Proc Inst Med Chic 30 1974 145-148
109. B. Morson President's address The polyp-cancer sequence in the large bowel. Proc R Soc Med 67 1974 451-457
110. B.C. Morson Some leads to the etiology of cancer of the large bowel Proc R Soc Med 64 1971 959-962
111. W.I. Wolff H. Shinya Polypectomy via the fiberoptic colonoscopy removal of neoplasms beyond reach of the sigmoidoscope N Engl J Med 288 1973 329-332
112. W.I. Wolff H. Shinya Endoscopic polypectomy Therapeutic and clinicopathologic aspects. Cancer 36 1975 683-690
113. S.J. Winawer A.G. Zauber M.N. Ho M.J. O'Brien L.S. Gottlieb S.S. Sternberg Prevention of colorectal cancer by colonoscopic polypectomy the National Polyp Study Workgroup N Engl J Med 329 1993 1977-1981
114. T. Takayama S. Katsuki Y. Takahashi M. Ohi S. Nojiri S. Sakamaki Aberrant crypt foci of the colon as precursors of adenoma and cancer N Engl J Med 339 1998 1277-1284
115. M. Stolte B. Bethke Colorectal mini-de novo carcinoma a reality in Germany too Endoscopy 27 1995 286-290
116. N.J. Hawkins R.L. Ward Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas J Natl Cancer Inst 93 2001 1307-1313
117. S.R. Hamilton Origin of colorectal cancers in hyperplastic polyps and serrated adenomas another truism bites the dust J Natl Cancer Inst 93 2001 1282-1283
118. K.W. Kinzler M.C. Nilbert L.K. Su B. Vogelstein T.M. Bryan D.B. Levy Identification of FAP locus genes from chromosome 5q21 Science 253 1991 661-665
119. C.R. Boland Hereditary nonpolyposis colorectal cancer B. Vogelstein K.W. Kinzler The genetic basis of human cancer 1998 McGraw-Hill New York 333-346
120. J.D. Potter Colorectal cancer molecules and populations J Natl Cancer Inst 91 1999 916-932
121. K.W. Kinzler B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159-170
122. B. Vogelstein E.R. Fearon S.R. Hamilton S.E. Kern A.C. Preisinger M. Leppert Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525-532
123. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759-767
124. S.A. Fuqua C. Wiltschke Q.X. Zhang A. Borg C.G. Castles W.E. Friedrichs A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions Cancer Res 60 2000 4026-4029
125. A.G. Knudson Jr. Mutation and cancer statistical study of retinoblastoma Proc Natl Acad Sci USA 68 1971 820-823
126. W.K. Cavenee Loss of heterozygosity in stages of malignancy Clin Chem 35 7 Suppl 1989 B48-B52
127. D. Kerr Clinical development of gene therapy for colorectal cancer Nat Rev Cancer 3 2003 615-622
128. R. Fodde R. Smits H. Clevers APC, signal transduction and genetic instability in colorectal cancer Nat Rev Cancer 1 2001 55-67
129. M. Ilyas J. Straub I.P. Tomlinson W.F. Bodmer Genetic pathways in colorectal and other cancers Eur J Cancer 35 1999 1986-2002
130. G. Marra C.R. Boland DNA repair and colorectal cancer Gastroenterol Clin North Am 25 1996 755-772
131. A. Umar T.A. Kunkel DNA-replication fidelity, mismatch repair and genome instability in cancer cells Eur J Biochem 238 1996 297-307
132. G. Marra C.R. Boland Hereditary nonpolyposis colorectal cancer the syndrome, the genes, and historical perspectives J Natl Cancer Inst 87 1995 1114-1125
133. J.T. Wijnen H.F. Vasen P.M. Khan A.H. Zwinderman H. van der Klift A. Mulder Clinical findings with implications for genetic testing in families with clustering of colorectal cancer N Engl J Med 339 1998 511-518
134. B. Liu R. Parsons N. Papadopoulos N.C. Nicolaides H.T. Lynch P. Watson Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients Nat Med 2 1996 169-174
135. A. Umar J.I. Risinger E.T. Hawk J.C. Barrett Testing guidelines for hereditary non-polyposis colorectal cancer Nat Rev Cancer 4 2004 153-158
136. K. Offit MSH6 mutations in hereditary nonpolyposis colon cancer another slice of the pie J Clin Oncol 22 2004 4449-4451
137. C.R. Boland S.N. Thibodeau S.R. Hamilton D. Sidransky J.R. Eshleman R.W. Burt A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248-5257
138. M.A. Rodriguez-Bigas C.R. Boland S.R. Hamilton D.E. Henson J.R. Jass P.M. Khan A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome meeting highlights and Bethesda guidelines J Natl Cancer Inst 89 1997 1758-1762
139. A. Umar C.R. Boland J.P. Terdiman S. Syngal A. de la Chapelle J. Ruschoff Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261-268
140. A. de la Chapelle Genetic predisposition to colorectal cancer Nat Rev Cancer 4 2004 769-780
141. J.M. Last A Dictionary of Epidemiology Third ed. 1995 Oxford University Press Oxford
142. H.T. Lynch A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919-932
143. W. Audeh Genetic predisposition to cancer malfunction or maladaptation? J.R. Bertino B.R. Goldspiel R.B. Herberman D.L. Longo E.K. Rowinsky L.S. Wood Horizons in Cancer Therapeutics 2003 Meniscus Educational Institute West Conshohocken, PA 3-18
144. Screening for Colorectal Cancer Guide to Clinical Preventive Services C. DiGuiseppi D. Atkins S.H. Woolf Report of the U.S. Preventive Services Task Force 2nd ed. 1996 Williams and Wilkins Baltimore 89-103
145. D.K. Rex D.A. Johnson D.A. Lieberman R.W. Burt A. Sonnenberg American College of Gastroenterology Colorectal cancer prevention 2000 screening recommendations of the American College of Gastroenterology Am J Gastroenterol 95 2000 868-877
146. R.S. McLeod Screening strategies for colorectal cancer a systematic review of the evidence Can J Gastroenterol 15 2001 647-660
147. S. Winawer R. Fletcher D. Rex J. Bond R. Burt J. Ferrucci Colorectal cancer screening and surveillance clinical guidelines and rationale-update based on new evidence Gastroenterology 124 2003 544-560
148. R.T. Villavicencio D.K. Rex Colonic adenomas prevalence and incidence rates, growth rates, and miss rates at colonoscopy Semin Gastrointest Dis 11 2000 185-193
149. W.S. Atkin B.C. Morson J. Cuzick Long-term risk of colorectal cancer after excision of rectosigmoid adenomas N Engl J Med 326 1992 658-662
150. S.J. Winawer A.G. Zauber M.J. O'Brien M.N. Ho L. Gottlieb S.S. Sternberg The National Polyp Study Workgroup Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps N Engl J Med 328 1993 901-906
151. L. Bertario A. Russo P. Sala P. Pizzetti G. Ballardini S. Andreola Risk of colorectal cancer following colonoscopic polypectomy Tumori 85 1999 157-162
152. K.C. Noshirwani R.U. van Stolk L.A. Rybicki G.J. Beck Adenoma size and number are predictive of adenoma recurrence implications for surveillance colonoscopy Gastrointest Endosc 51 4 Pt 1 2000 433-437
153. T.R. Levin A. Palitz S. Grossman C. Conell L. Finkler L. Ackerson Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy JAMA 281 1999 1611-1617
154. S.J. Winawer R.H. Fletcher L. Miller F. Godlee M.H. Stolar C.D. Mulrow Colorectal cancer screening clinical guidelines and rationale Gastroenterology 112 1997 594-642
155. USPSTF Screening for Colorectal Cancer, Recommendations and Rationale, U.S. Preventive Services Task Force 2002 http://www.ahrq.gov/clinic/3rduspstf/colorectal/colorr.htm. December 2004.
156. J.S. Mandel J.H. Bond T.R. Church D.C. Snover G.M. Bradley L.M. Schuman Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med 328 1993 1365-1371
157. D.A. Ahlquist Fecal occult blood testing for colorectal cancer Can we afford to do this? Gastroenterol Clin North Am 26 1997 41-55
158. S.W. Vernon Participation in colorectal cancer screening a review J Natl Cancer Inst 89 1997 1406-1422
159. E.J. Bini R.C. Rajapaksa E.H. Weinshel The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study a comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients Arch Intern Med 159 1999 2022-2026
160. D.F. Ransohoff C.A. Lang American College of Physicians Screening for colorectal cancer with the fecal occult blood test a background paper [see comments]. Ann Intern Med 126 1997 811-822
161. V.A. Gilbertsen T.R. Church F.J. Grewe J.S. Mandel R.B. McHugh L.M. Schuman The design of a study to assess occult-blood screening for colon cancer J Chronic Dis 33 1980 107-114
162. J.D. Hardcastle J.O. Chamberlain M.H. Robinson S.M. Moss S.S. Amar T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472-1477
163. J.D. Hardcastle W.M. Thomas J. Chamberlain G. Pye J. Sheffield P.D. James Randomised, controlled trial of faecal occult blood screening for colorectal cancer Results for first 107,349 subjects. Lancet 1 1989 1160-1164
164. O. Kronborg C. Fenger J. Olsen K. Bech O. Sondergaard Repeated screening for colorectal cancer with fecal occult blood test: A prospective randomized study at Funen, Denmark Scand J Gastroenterol 24 1989 599-606
165. O. Kronborg C. Fenger J. Olsen O.D. Jorgensen O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult- blood test Lancet 348 1996 1467-1471
166. J. Kewenter S. Bjork E. Haglind L. Smith J. Svanvik C. Ahren Screening and rescreening for colorectal cancer a controlled trial of fecal occult blood testing in 27,700 subjects Cancer 62 1988 645-651
167. J. Kewenter H. Brevinge B. Engaras E. Haglind C. Ahren Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing Results for 68,308 subjects. Scand J Gastroenterol 29 1994 468-473
168. J. Kewenter H. Brevinge Endoscopic and surgical complications of work-up in screening for colorectal cancer Dis Colon Rectum 39 1996 676-680
169. J.S. Mandel J.H. Bond M. Bradley D.C. Snover T.R. Church S. Williams Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers The University of Minnesota's Colon Cancer Control Study. Gastroenterology 97 1989 597-600
170. B.P. Towler L. Irwig P. Glasziou D. Weller J. Kewenter Screening for colorectal cancer using the faecal occult blood test, hemoccult Cochrane Database Syst Rev 2 2000 CD001216
171. G.P. Young Screening for colorectal cancer alternative faecal occult blood tests Eur J Gastroenterol Hepatol 10 1998 205-212
172. C.M. Rembold Number needed to screen development of a statistic for disease screening BMJ 317 1998 307-312
173. J.E. Allison I.S. Tekawa L.J. Ransom A.L. Adrain A comparison of fecal occult-blood tests for colorectal-cancer screening [see comments]. N Engl J Med 334 1996 155-159
174. B. Levin D. Brooks R.A. Smith A. Stone Emerging technologies in screening for colorectal cancer CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers CA Cancer J Clin 53 2003 44-55
175. D.A. Ahlquist J.E. Skoletsky K.A. Boynton J.J. Harrington D.W. Mahoney W.E. Pierceall Colorectal cancer screening by detection of altered human DNA in stool feasibility of a multitarget assay panel Gastroenterology 119 2000 1219-1227
176. S.M. Dong G. Traverso C. Johnson L. Geng R. Favis K. Boynton Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 93 2001 858-865
177. S.M. Scheitel D.A. Ahlquist P.C. Wollan P.T. Hagen M.D. Silverstein Colorectal cancer screening a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy Mayo Clin Proc 74 1999 1207-1213
178. D.K. Rex E.Y. Rahmani J.H. Haseman G.T. Lemmel S. Kaster J.S. Buckley Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice Gastroenterology 112 1997 17-23
179. S.J. Winawer E.T. Stewart A.G. Zauber J.H. Bond H. Ansel J.D. Waye National Polyp Study Work Group A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy [see comments]. N Engl J Med 342 2000 1766-1772
180. P.J. Pickhardt J.R. Choi I. Hwang J.A. Butler M.L. Puckett H.A. Hildebrandt Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults N Engl J Med 349 2003 2191-2200
181. P.B. Cotton V.L. Durkalski B.C. Pineau Y.Y. Palesch P.D. Mauldin B. Hoffman Computed tomographic colonography (virtual colonoscopy) a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia JAMA 291 2004 1713-1719
182. J.H. Bond Virtual colonoscopy - promising, but not ready for widespread use N Engl J Med 341 1999 1540-1542
183. A.D. Muller A. Sonnenberg Protection by endoscopy against death from colorectal cancer a case-control study among veterans Arch Intern Med 155 1995 1741-1748
184. A.D. Muller A. Sonnenberg Prevention of colorectal cancer by flexible endoscopy and polypectomy a case-control study of 32,702 veterans Ann Intern Med 123 1995 904-910
185. P.A. Newcomb R.G. Norfleet B.E. Storer T.S. Surawicz P.M. Marcus Screening sigmoidoscopy and colorectal cancer mortality J Natl Cancer Inst 84 1992 1572-1575
186. J.V. Selby G.D. Friedman C.P. Quesenberry Jr N.S. Weiss A case-control study of screening sigmoidoscopy and mortality from colorectal cancer N Engl J Med 326 1992 653-657
187. A.M. Kavanagh E.L. Giovannucci C.S. Fuchs G.A. Colditz Screening endoscopy and risk of colorectal cancer in United States men Cancer Causes Control 9 1998 455-462
188. K.C. Chu R.E. Tarone W.H. Chow G.A. Alexander Colorectal cancer trends by race and anatomic subsites, 1975 to 1991 Arch Fam Med 4 1995 849-856
189. L.A. Ries P.A. Wingo D.S. Miller H.L. Howe H.K. Weir H.M. Rosenberg The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer Cancer 88 2000 2398-2424
190. E. Thiis-Evensen G.S. Hoff J. Sauar F. Langmark B.M. Majak M.H. Vatn Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer. Telemark Polyp Study I Scand J Gastroenterol 34 1999 414-420
191. W.S. Atkin A. Hart R. Edwards P. McIntyre R. Aubrey J. Wardle Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening Gut 42 1998 560-565
192. B.S. Kramer J. Gohagan P.C. Prorok C. Smart A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers Cancer 71 2 Suppl 1993 589-593
193. T.F. Imperiale D.R. Wagner C.Y. Lin G.N. Larkin J.D. Rogge D.F. Ransohoff Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343 2000 169-174
194. D.A. Lieberman D.G. Weiss J.H. Bond D.J. Ahnen H. Garewal G. Chejfec Veterans Affairs Cooperative Study Group 380 Use of colonoscopy to screen asymptomatic adults for colorectal cancer N Engl J Med 343 2000 162-168
195. D.A. Lieberman D.G. Weiss One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 345 2001 555-560
196. S.J. Winawer B.J. Flehinger D. Schottenfeld D.G. Miller Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy J Natl Cancer Inst 85 1993 1311-1318
197. J.V. Selby G.D. Friedman C.P. Quesenberry Jr N.S. Weiss Effect of fecal occult blood testing on mortality from colorectal cancer a case-control study Ann Intern Med 118 1993 1-6
198. D.P. Berry P. Clarke J.D. Hardcastle K.D. Vellacott Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening Br J Surg 84 1997 1274-1276
199. M. Rasmussen O. Kronborg C. Fenger O.D. Jorgensen Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer: A randomized study Scand J Gastroenterol 34 1999 73-78
200. J.A. Baron M. Beach J.S. Mandel R.U. van Stolk R.W. Haile R.S. Sandler Calcium Polyp Prevention Study Group Calcium supplements for the prevention of colorectal adenomas N Engl J Med 340 1999 101-107
201. D.K. Podolsky Going the distance - the case for true colorectal-cancer screening [comment] [editorial] N Engl J Med 343 2000 207-208
202. D. Lieberman Colonoscopy as good as gold? Ann Intern Med 141 2004 401-403
203. J.D. Waye S. Braunfeld Surveillance intervals after colonoscopic polypectomy Endoscopy 14 1982 79-81
204. L.J. Hixson M.B. Fennerty R.E. Sampliner H.S. Garewal Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps Gastrointest Endosc 37 1991 125-127
205. L.J. Hixson M.B. Fennerty R.E. Sampliner D. McGee H. Garewal Prospective study of the frequency and size distribution of polyps missed by colonoscopy J Natl Cancer Inst 82 1990 1769-1772
206. D.K. Rex C.S. Cutler G.T. Lemmel E.Y. Rahmani D.W. Clark D.J. Helper Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies Gastroenterology 112 1997 24-28
207. P.J. Pickhardt P.A. Nugent P.A. Mysliwiec J.R. Choi W.R. Schindler Location of adenomas missed by optical colonoscopy Ann Intern Med 141 2004 352-359
208. M.L. Anderson T.M. Pasha J.A. Leighton Endoscopic perforation of the colon lessons from a 10-year study Am J Gastroenterol 95 2000 3418-3422
209. G. Winnan G. Berci J. Panish T.M. Talbot B.F. Overholt R.W. McCallum Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy N Engl J Med 302 1980 1011-1012
210. O.W. Cass Objective evaluation of competence technical skills in gastrointestinal endoscopy Endoscopy 27 1995 86-89
211. O.W. Cass M.L. Freeman C.J. Peine R.T. Zera G.R. Onstad Objective evaluation of endoscopy skills during training Ann Intern Med 118 1993 40-44
212. W.F. Anderson K.Z. Guyton R.A. Hiatt S.W. Vernon B. Levin E.T. Hawk Colorectal cancer screening for persons at average risk J Natl Cancer Inst 94 2002 1126-1133
213. United States Census Bureau 2000 population estimates 2000 www.census.gov. December 2004.
214. Physician characteristics and distribution in the U.S. Survey and data resources. Chicago (IL): The American Medical Association; edition 2001-2002.
215. Trends in Screening for Colorectal Cancer-United States, 1997 and 1999 MMWR Morb Mortal Wkly Rep 50 2001 162
216. G.A. Brenes E.D. Paskett Predictors of stage of adoption for colorectal cancer screening Prev Med 31 2000 410-416
217. L.C. Friedman J.A. Webb C.S. Richards S.E. Plon Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim Prev Med 29 1999 119-125
218. M.S. O'Malley J.A. Earp S.T. Hawley M.J. Schell H.F. Mathews J. Mitchell The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography who gets the message about breast cancer screening? Am J Public Health 91 2001 49-54
219. D.S. May C.I. Kiefe E. Funkhouser M.N. Fouad Compliance with mammography guidelines physician recommendation and patient adherence Prev Med 28 1999 386-394
220. N.M. MacDowell M. Nitz-Weiss A. Short The role of physician communication in improving compliance with mammography screening among women ages 50-79 in a commercial HMO Manag Care Q 8 2000 11-19
221. S.A. Fox A.L. Siu J.A. Stein The importance of physician communication on breast cancer screening of older women Arch Intern Med 154 1994 2058-2068
222. S.K. Peterson S.W. Vernon A review of patient and physician adherence to colorectal cancer screening guidelines Semin Colon Rectal Surg 11 2000 58-72
223. P.A. Mysliwiec M.L. Brown C.N. Klabunde D.F. Ransohoff Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy Ann Intern Med 141 2004 264-271
224. A.L. Frazier G.A. Colditz C.S. Fuchs K.M. Kuntz Cost-effectiveness of screening for colorectal cancer in the general population JAMA 284 2000 1954-1961
225. D.A. Lieberman Cost-effectiveness model for colon cancer screening Gastroenterology 109 1995 1781-1790
226. R.K. Khandker J.D. Dulski J.B. Kilpatrick R.P. Ellis J.B. Mitchell W.B. Baine A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults Int J Technol Assess Health Care 16 2000 799-810
227. A. Sonnenberg F. Delco J.M. Inadomi Cost-effectiveness of colonoscopy in screening for colorectal cancer Ann Intern Med 133 2000 573-584
228. R.M. Ness A.M. Holmes R. Klein R. Dittus Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages Am J Gastroenterol 95 2000 1800-1811
229. F. Loeve M.L. Brown R. Boer M. van Ballegooijen G.J. van Oortmarssen J.D. Habbema Endoscopic colorectal cancer screening a cost-saving analysis [see comments] J Natl Cancer Inst 92 2000 557-563
230. J.D. Lewis D.A. Asch Barriers to office-based screening sigmoidoscopy does reimbursement cover costs? Ann Intern Med 130 1999 525-530
231. Gertenberger PD, Plumeri PA. Malpractice claims in gastrointestinal endoscopy: Analysis of an insurance industry data base. Gastrointest Endosc 1993;39:132-8.